Calumet, Inc. (NASDAQ:CLMT) SVP Sells $419,302.87 in Stock

Calumet, Inc. (NASDAQ:CLMT - Get Free Report) SVP Gregory J. Morical sold 25,123 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $16.69, for a total transaction of $419,302.87. Following the transaction, the senior vice president now directly owns 39,415 shares of the company's stock, valued at approximately $657,836.35. This trade represents a 38.93% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Calumet Stock Performance

Shares of CLMT stock traded down $0.06 during mid-day trading on Friday, hitting $16.37. 1,463,834 shares of the stock traded hands, compared to its average volume of 967,974. The firm has a market cap of $1.41 billion, a price-to-earnings ratio of -4.09 and a beta of 0.91. The company's 50-day simple moving average is $12.65 and its 200-day simple moving average is $15.21. Calumet, Inc. has a twelve month low of $7.68 and a twelve month high of $25.29.

Calumet (NASDAQ:CLMT - Get Free Report) last issued its quarterly earnings results on Friday, May 9th. The oil and gas company reported ($1.03) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.62). The business had revenue of $993.90 million for the quarter, compared to analysts' expectations of $899.62 million. During the same quarter in the previous year, the business posted ($0.51) EPS. The company's quarterly revenue was down 1.2% compared to the same quarter last year. Analysts forecast that Calumet, Inc. will post -3.02 earnings per share for the current year.

Analyst Ratings Changes

Several analysts recently weighed in on CLMT shares. The Goldman Sachs Group cut their price objective on shares of Calumet from $16.00 to $14.00 and set a "buy" rating on the stock in a research report on Wednesday, April 30th. Bank of America assumed coverage on Calumet in a research report on Tuesday, May 13th. They set a "buy" rating and a $15.00 price objective for the company. HC Wainwright restated a "buy" rating and issued a $33.00 target price on shares of Calumet in a research report on Monday, March 3rd. Wells Fargo & Company cut their target price on Calumet from $23.00 to $21.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Finally, UBS Group raised Calumet from a "sell" rating to a "neutral" rating and lowered their price target for the company from $15.00 to $12.00 in a report on Monday, March 17th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $18.50.

Calumet Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.